Additional information
White Powder
265989-44-4
ACI-011225
208.2-209.0°C
C33H34FN2NaO6
596.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
4-Hydroxy atorvastatin





![LINAGLIPTIN DES-PIPERIDINE AMINE (25 mg) (7-(2-Butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-3,7-dihydro-1H-purine-2,6-dione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)